Preclinical characterization of SM2248: A dual-action bispecific antibody enhancing immunotherapy for solid tumorsCANCER RESEARCHIF16.62024-03-220PRE
SM2275, A tetraspecific, dual EGFR and PD-L1-targeting, conditionally activating co-stimulatory CD28 and simultaneously blocking PD-1/PD-L1 signaling to promoting fully activated T cell killing effects on tumor cellsCANCER RESEARCHIF16.62024-03-220PRE
SM2256: A bispecific conditional CD40 and 4-1BB dual agonist for enhanced solid tumor immune responseCANCER RESEARCHIF16.62024-03-220PRE
SM2235: A bispecific EGFR x CD16A innate immune cell engager for enhanced treatment of EGFR-expressing solid tumors, regardless of RAS mutation statusCANCER RESEARCHIF16.62024-03-220PRE
Photoreceptor degeneration in microphthalmia (Mitf) mice: partial rescue by pigment epithelium-derived factorDISEASE MODELS & MECHANISMSIF3.32019-01-1130OAAI
Regulation of pigmentation by microRNAs: MITF-dependent microRNA-211 targets TGF-β receptor 2PIGMENT CELL & MELANOMA RESEARCHIF2.62015-01-0753PREAI